Literature DB >> 19123922

C-Terminal membrane spanning region of human heme oxygenase-1 mediates a time-dependent complex formation with cytochrome P450 reductase.

Warren J Huber Iii1, Brittni A Scruggs, Wayne L Backes.   

Abstract

Heme oxygenase-1 (HO-1) catalyzes the oxidative degradation of heme to biliverdin, carbon monoxide, and free iron in a reaction requiring the interaction of HO-1 with NADPH-cytochrome P450 reductase (CPR). HO-1 is bound to the endoplasmic reticulum by 23 C-terminal amino acids; however, a soluble HO-1 (sHO-1) lacking this membrane spanning region has been extensively studied. The goal of this project was to characterize the effect of the C-terminal hydrophobic domain on formation of the HO-1/CPR complex. Full-length HO-1 was shown to exhibit higher reaction rates than sHO-1, particularly at subsaturating CPR, indicating that the C-terminal region influences HO-1 binding to CPR. The increased activity of HO-1 was attributable to a time-dependent formation of a low K(m) HO-1/CPR complex that was not seen with sHO1. Gel filtration analysis confirmed the formation of multiple high molecular weight complexes in the presence and absence of the synthetic lipid dilauroylphosphatidylcholine (DLPC). However, the largest complex appeared following a 2 h incubation of HO-1 and CPR in DLPC, suggesting that the C-terminal region was required for the high-affinity HO-1/CPR complex formation and membrane incorporation. These data demonstrate that the C-terminal region of HO-1 influenced complex formation and ultimately its affinity for CPR.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19123922      PMCID: PMC2789667          DOI: 10.1021/bi801912z

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  61 in total

1.  Purification and properties of heme oxygenase from pig spleen microsomes.

Authors:  T Yoshida; G Kikuchi
Journal:  J Biol Chem       Date:  1978-06-25       Impact factor: 5.157

2.  Microsomal heme oxygenase. Characterization of the enzyme.

Authors:  R Tenhunen; H S Marver; R Schmid
Journal:  J Biol Chem       Date:  1969-12-10       Impact factor: 5.157

3.  Immunochemical evidence for an association of heme oxygenase with the microsomal electron transport system.

Authors:  B A Schacter; E B Nelson; H S Marver; B S Masters
Journal:  J Biol Chem       Date:  1972-06-10       Impact factor: 5.157

4.  The occurrence of molecular interactions among NADPH-cytochrome c reductase, heme oxygenase, and biliverdin reductase in heme degradation.

Authors:  T Yoshinaga; S Sassa; A Kappas
Journal:  J Biol Chem       Date:  1982-07-10       Impact factor: 5.157

5.  Some properties of a detergent-solubilized NADPH-cytochrome c(cytochrome P-450) reductase purified by biospecific affinity chromatography.

Authors:  Y Yasukochi; B S Masters
Journal:  J Biol Chem       Date:  1976-09-10       Impact factor: 5.157

6.  Cobalt induction of hepatic heme oxygenase; with evidence that cytochrome P-450 is not essential for this enzyme activity.

Authors:  M D Maines; A Kappas
Journal:  Proc Natl Acad Sci U S A       Date:  1974-11       Impact factor: 11.205

7.  Expression and characterization of full-length human heme oxygenase-1: the presence of intact membrane-binding region leads to increased binding affinity for NADPH cytochrome P450 reductase.

Authors:  Warren J Huber; Wayne L Backes
Journal:  Biochemistry       Date:  2007-10-04       Impact factor: 3.162

8.  Purification and properties of heme oxygenase from rat liver microsomes.

Authors:  T Yoshida; G Kikuchi
Journal:  J Biol Chem       Date:  1979-06-10       Impact factor: 5.157

9.  Purification and characterization of biliverdin reductase from rat liver.

Authors:  R K Kutty; M D Maines
Journal:  J Biol Chem       Date:  1981-04-25       Impact factor: 5.157

10.  Purification and properties of bovine spleen heme oxygenase. Amino acid composition and sites of action of inhibitors of heme oxidation.

Authors:  T Yoshinaga; S Sassa; A Kappas
Journal:  J Biol Chem       Date:  1982-07-10       Impact factor: 5.157

View more
  9 in total

1.  Dynamic and structural differences between heme oxygenase-1 and -2 are due to differences in their C-terminal regions.

Authors:  Brent A Kochert; Angela S Fleischhacker; Thomas E Wales; Donald F Becker; John R Engen; Stephen W Ragsdale
Journal:  J Biol Chem       Date:  2019-04-03       Impact factor: 5.157

2.  Structural insights into human heme oxygenase-1 inhibition by potent and selective azole-based compounds.

Authors:  Mona N Rahman; Dragic Vukomanovic; Jason Z Vlahakis; Walter A Szarek; Kanji Nakatsu; Zongchao Jia
Journal:  J R Soc Interface       Date:  2012-11-08       Impact factor: 4.118

3.  Mutations of human cytochrome P450 reductase differentially modulate heme oxygenase-1 activity and oligomerization.

Authors:  Christopher C Marohnic; Warren J Huber Iii; J Patrick Connick; James R Reed; Karen McCammon; Satya P Panda; Pavel Martásek; Wayne L Backes; Bettie Sue S Masters
Journal:  Arch Biochem Biophys       Date:  2011-06-28       Impact factor: 4.013

4.  The iron chaperone poly(rC)-binding protein 2 forms a metabolon with the heme oxygenase 1/cytochrome P450 reductase complex for heme catabolism and iron transfer.

Authors:  Izumi Yanatori; Des R Richardson; Shinya Toyokuni; Fumio Kishi
Journal:  J Biol Chem       Date:  2017-06-27       Impact factor: 5.157

5.  Inhibition of cytochrome P450 1A2-mediated metabolism and production of reactive oxygen species by heme oxygenase-1 in rat liver microsomes.

Authors:  James R Reed; George F Cawley; Wayne L Backes
Journal:  Drug Metab Lett       Date:  2011-01

6.  Measurement of membrane-bound human heme oxygenase-1 activity using a chemically defined assay system.

Authors:  Warren J Huber; Christopher C Marohnic; Michelle Peters; Jawed Alam; James R Reed; Bettie Sue Siler Masters; Wayne L Backes
Journal:  Drug Metab Dispos       Date:  2009-01-08       Impact factor: 3.922

7.  Heme oxygenase isoforms differ in their subcellular trafficking during hypoxia and are differentially modulated by cytochrome P450 reductase.

Authors:  Monika Linnenbaum; Mareike Busker; Jan R Kraehling; Soenke Behrends
Journal:  PLoS One       Date:  2012-04-24       Impact factor: 3.240

8.  A novel, "double-clamp" binding mode for human heme oxygenase-1 inhibition.

Authors:  Mona N Rahman; Jason Z Vlahakis; Dragic Vukomanovic; Wallace Lee; Walter A Szarek; Kanji Nakatsu; Zongchao Jia
Journal:  PLoS One       Date:  2012-01-19       Impact factor: 3.240

9.  Translocation of heme oxygenase-1 contributes to imatinib resistance in chronic myelogenous leukemia.

Authors:  Bianca Schaefer; Soenke Behrends
Journal:  Oncotarget       Date:  2017-06-27
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.